Effects of long-term treatment with human recombinant erythropoietin in patients on CAPD.
Steinhauer
H B
HB
Department of Internal Medicine, University of Freiburg, F.R.G.
D000328:Adult; D000368:Aged; D000740:Anemia / Q000150:complications / Q000188:drug therapy / Q000209:etiology*; D001809:Blood Viscosity; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006400:Hematocrit; D006801:Humans; D007674:Kidney Diseases / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011994:Recombinant Proteins / Q000627:therapeutic use; D014462:Ultrafiltration
D011994:Recombinant Proteins; D004921:Erythropoietin